Replay available

Oscar Health, Inc. (OSCR) Q2 2025 Earnings Call

Oscar Health, Inc. (NYSE: OSCR) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.

Wed, August 6, 2025 at 8:00 AMendedReplay
Oscar Health, Inc. (OSCR) Q2 2025 Earnings Call

Investor webinar replay

Latest news releases

Companies on this event

Featured Presenters

Chris Portachar

Vice President of Treasury and Investor Relations

Mark Bertolini

Chief Executive Officer

Scott Blackley

Chief Financial Officer

Josh Raskin

Analyst at Neffron Research

Michael Hough

Analyst

Jessica Tassan

Analyst at Piper Samuel

John Ransom

Analyst at Raymond James

Stephen Baxter

Analyst at Wells Fargo

Jonathan Young

Analyst at UBS

Craig Jones

Analyst at Bank of America

Dave Wendley

Analyst at Jeffreys

Andrew Mock

Analyst at Barclays

Replay transcript excerpt

Star 1 again. Thank you. I will now turn the conference over to Chris Portachar, Vice President of Treasury and Investor Relations. Please go ahead. Good morning, everyone. Thank you for joining us for our second quarter 2025 earnings call. Mark Berlini, Oscar Hell's Chief Executive Officer, and Scott Blackley, Oscar's Chief Financial Officer, will host this morning's call. This call can also be accessed through our investor relations website at .hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our investor relations website at .hioscar.com. Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our annual report on Form 10-K for the period ended December 31, 2024, and the quarterly report on Form 10-Q for the period ended March 31, 2025, each is filed with the SEC, and other filings with the SEC, including our quarterly report on Form 10-Q for the quarterly period ended June 30, 2025, to be filed with the SEC. Such forward-looking statements are based on current expectations as of today. Oscar anticipates that subsequent events and developments may cause estimates to change. While the company may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. The call will also refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in the second qu...

More from Oscar Health, Inc.